Zeban Nominees Limited investment portfolio

Burgopak Holdings Limited designs and supplies custom packaging solutions, specialising in sustainable, user‑centred designs for healthcare, medical device and consumer brands.

Oxford Drug Design Limited provides AI‑driven drug‑discovery services that design and develop novel therapeutics, including antibiotics for multidrug‑resistant infections and treatments for cancer and other major diseases, serving pharmaceutical and biotechnology companies.